| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 112,052 | 101,750 | 101,635 | 89,626 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 112,052 | 101,750 | 101,635 | 89,626 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 73,293 | 60,843 | 74,941 | 65,860 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 9,949 | 6,727 | 12,479 | 12,620 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 28,810 | 34,180 | 14,215 | 11,146 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 28,810 | 34,180 | 14,215 | 11,146 | | Interest Expense | 21,898 | 21,700 | 21,174 | 21,780 | | Income Before Tax | 6,912 | 12,480 | (6,959) | (10,634) | | Income Tax Expense | 1,731 | 4,436 | (2,411) | (3,483) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 5,181 | 8,044 | (4,548) | (7,151) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 5,181 | 8,044 | (4,548) | (7,151) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $5,181 | $8,044 | ($4,548) | ($7,151) |
|
0.63% Nasdaq 
Income Statement
